BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24953403)

  • 1. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.
    Dunbar M; Jaggumantri S; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
    Mol Genet Metab; 2014 Aug; 112(4):259-74. PubMed ID: 24953403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Creatine Transporter (SLC6A8) Deficiency With Oral S-Adenosyl Methionine as Adjunct to L-arginine, Glycine, and Creatine Supplements.
    Jaggumantri S; Dunbar M; Edgar V; Mignone C; Newlove T; Elango R; Collet JP; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
    Pediatr Neurol; 2015 Oct; 53(4):360-363.e2. PubMed ID: 26205312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine Transporter Deficiency in Two Brothers with Autism Spectrum Disorder.
    Aydin HI
    Indian Pediatr; 2018 Jan; 55(1):67-68. PubMed ID: 29396939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dodecyl creatine ester therapy: from promise to reality.
    Mabondzo A; van de Kamp J; Mercimek-Andrews S
    Cell Mol Life Sci; 2024 Apr; 81(1):186. PubMed ID: 38632116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease.
    Mejdahl Nielsen M; Petersen ET; Fenger CD; Ørngreen MC; Siebner HR; Boer VO; Považan M; Lund A; Grønborg SW; Hammer TB
    Mol Genet Metab; 2023 Nov; 140(3):107694. PubMed ID: 37708665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Stockler-Ipsiroglu S; van Karnebeek CD
    Semin Neurol; 2014 Jul; 34(3):350-6. PubMed ID: 25192512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine Transporter Deficiency: Screening of Males with Neurodevelopmental Disorders and Neurocognitive Characterization of a Case.
    Thurm A; Himelstein D; DʼSouza P; Rennert O; Jiang S; Olatunji D; Longo N; Pasquali M; Swedo S; Salomons GS; Carrillo N
    J Dev Behav Pediatr; 2016 May; 37(4):322-6. PubMed ID: 27096572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency.
    Ullio-Gamboa G; Udobi KC; Dezard S; Perna MK; Miles KN; Costa N; Taran F; Pruvost A; Benoit JP; Skelton MR; Lonlay P; Mabondzo A
    Nanomedicine (Lond); 2019 Jun; 14(12):1579-1593. PubMed ID: 31038003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
    Cacciante F; Gennaro M; Sagona G; Mazziotti R; Lupori L; Cerri E; Putignano E; Butt M; Do MT; McKew JC; Alessandrì MG; Battini R; Cioni G; Pizzorusso T; Baroncelli L
    Sci Rep; 2020 Oct; 10(1):18361. PubMed ID: 33110151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic variability in a portuguese family with x-linked creatine transport deficiency.
    Garcia P; Rodrigues F; Valongo C; Salomons GS; Diogo L
    Pediatr Neurol; 2012 Jan; 46(1):39-41. PubMed ID: 22196490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency (
    Curie A; Lion-François L; Valayannopoulos V; Perreton N; Gavanon M; Touil N; Brun-Laurisse A; Gheurbi F; Buchy M; Halep H; Cheillan D; Mercier C; Brassier A; Desnous B; Kassai B; De Lonlay P; Des Portes V
    Neurology; 2024 Apr; 102(8):e209243. PubMed ID: 38531017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency.
    van de Kamp JM; Betsalel OT; Mercimek-Mahmutoglu S; Abulhoul L; Grünewald S; Anselm I; Azzouz H; Bratkovic D; de Brouwer A; Hamel B; Kleefstra T; Yntema H; Campistol J; Vilaseca MA; Cheillan D; D'Hooghe M; Diogo L; Garcia P; Valongo C; Fonseca M; Frints S; Wilcken B; von der Haar S; Meijers-Heijboer HE; Hofstede F; Johnson D; Kant SG; Lion-Francois L; Pitelet G; Longo N; Maat-Kievit JA; Monteiro JP; Munnich A; Muntau AC; Nassogne MC; Osaka H; Ounap K; Pinard JM; Quijano-Roy S; Poggenburg I; Poplawski N; Abdul-Rahman O; Ribes A; Arias A; Yaplito-Lee J; Schulze A; Schwartz CE; Schwenger S; Soares G; Sznajer Y; Valayannopoulos V; Van Esch H; Waltz S; Wamelink MM; Pouwels PJ; Errami A; van der Knaap MS; Jakobs C; Mancini GM; Salomons GS
    J Med Genet; 2013 Jul; 50(7):463-72. PubMed ID: 23644449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel SLC6A8 mutation associated with intellectual disabilities in a Chinese family exhibiting creatine transporter deficiency: case report.
    Wang Q; Yang J; Liu Y; Li X; Luo F; Xie J
    BMC Med Genet; 2018 Nov; 19(1):193. PubMed ID: 30400883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine transporter deficiency, an underdiagnosed cause of male intellectual disability.
    Jangid N; Surana P; Salmonos G; Jain V
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33334757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
    Passi GR; Pandey S; Devi ARR; Konanki R; Jain AR; Bhatnagar S; Tripathi R; Jain V
    Brain Dev; 2022 Apr; 44(4):271-280. PubMed ID: 34974949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of creatine transport and metabolism.
    Longo N; Ardon O; Vanzo R; Schwartz E; Pasquali M
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):72-8. PubMed ID: 21308988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intractable epilepsy in a female with SLC6A8 deficiency.
    Mercimek-Mahmutoglu S; Connolly MB; Poskitt KJ; Horvath GA; Lowry N; Salomons GS; Casey B; Sinclair G; Davis C; Jakobs C; Stockler-Ipsiroglu S
    Mol Genet Metab; 2010 Dec; 101(4):409-12. PubMed ID: 20846889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC6A8 creatine transporter deficiency can be detected by plasma creatine and creatinine concentrations.
    Sanders K; Peck D; Bentz Pino G; Studinski Jones A; White A; Gavrilov D; Matern D; Oglesbee D; Schultz M; Tortorelli S; Hall PL
    Mol Genet Metab; 2024 May; 142(1):108455. PubMed ID: 38531184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable White Matter Atrophy and Intellectual Development in a Family With X-linked Creatine Transporter Deficiency Despite Genotypic Homogeneity.
    Heussinger N; Saake M; Mennecke A; Dörr HG; Trollmann R
    Pediatr Neurol; 2017 Feb; 67():45-52. PubMed ID: 28065824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.
    Stockler S; Schutz PW; Salomons GS
    Subcell Biochem; 2007; 46():149-66. PubMed ID: 18652076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.